Overview

Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
To assess the effectiveness of alverine citrate and simeticone on IBS symptoms according to the latest recommended design
Phase:
Phase 4
Details
Lead Sponsor:
Laboratoires Mayoly Spindler
Treatments:
Alverine
Mebeverine